AGTC - Applied Genetic Technologies Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
148.66M
Enterprise Value 3
82.82M
Trailing P/E
N/A
Forward P/E 1
-4.48
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
5.38
Price/Book (mrq)
2.19
Enterprise Value/Revenue 3
2.99
Enterprise Value/EBITDA 6
-5.23

Trading Information

Stock Price History

Beta (5Y Monthly) 2.71
52-Week Change 3172.82%
S&P500 52-Week Change 325.98%
52 Week High 39.50
52 Week Low 32.52
50-Day Moving Average 34.46
200-Day Moving Average 33.66

Share Statistics

Avg Vol (3 month) 3993.86k
Avg Vol (10 day) 36.59M
Shares Outstanding 518.22M
Float 11.37M
% Held by Insiders 117.78%
% Held by Institutions 162.01%
Shares Short (Dec 30, 2019) 4157.87k
Short Ratio (Dec 30, 2019) 40.48
Short % of Float (Dec 30, 2019) 40.88%
Short % of Shares Outstanding (Dec 30, 2019) 40.87%
Shares Short (prior month Nov 28, 2019) 491.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2019
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -53.45%
Operating Margin (ttm)-61.81%

Management Effectiveness

Return on Assets (ttm)-10.58%
Return on Equity (ttm)-20.13%

Income Statement

Revenue (ttm)27.66M
Revenue Per Share (ttm)1.52
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)27.86M
EBITDA -15.82M
Net Income Avi to Common (ttm)-14.78M
Diluted EPS (ttm)-0.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.11M
Total Cash Per Share (mrq)3.9
Total Debt (mrq)5.81M
Total Debt/Equity (mrq)8.55
Current Ratio (mrq)7.95
Book Value Per Share (mrq)3.73

Cash Flow Statement

Operating Cash Flow (ttm)-34.76M
Levered Free Cash Flow (ttm)-22.19M